Autopsy report · NCT00005852

Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

“low accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years after it had already started.
• Ran for about 11 years 1 month before it stopped.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Sponsor type

University, hospital or other

Conditions

Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes

Interventions

anti-thymocyte globulin; filgrastim; muromonab-CD3; cyclophosphamide; cyclosporine; methylprednisolone

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.